Sign in
Taking peopleNo phase

Efficacy of Ultrasound-guided Greater Auricular Nerve Block in Preventing Postoperative Emergence Agitation in Pediatric Patients Undergoing Microscopic Middle Ear Surgery.

Key facts

Who runs it
Fayoum University
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Recruiting
People taking part
74 people, planned
Started
1 Aug 2025
Planned end
1 Apr 2026
Type of study
Interventional, 2 groupsOne group gets no study treatment, for comparison.
Treatments tested
  • ultrasound-guided greater auricular nerve block (GANB)
Record updated
27 February 2026

Who can take part

Age
5 years to 14 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Age between 5 and 14 years (preschool to early school age group at highest risk for EA)
  • ASA physical status I or II
  • Scheduled for elective microscopic middle ear surgery under general anesthesia (e.g., tympanoplasty, myringoplasty)
  • Ability to comply with FLACC and PAED scoring during postoperative period
  • Informed consent obtained from a parent or legal guardian

Who cannot take part

  • Known neurological, developmental, or psychiatric disorders (e.g., autism, ADHD, seizure disorder)
  • Known hypersensitivity to amide local anesthetics (e.g., lidocaine, bupivacaine)
  • Skin infection, hematoma, or trauma at or near the proposed block site
  • Inability to assess pain or agitation due to hearing loss, or communication impairment
  • Non-elective (emergency) or combined surgeries
  • Parental or legal guardian refusal to participate

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 5 and 14 years old?

This trial is currently available in Egypt.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This study is designed to evaluate the effectiveness of ultrasound-guided greater auricular nerve block (GAN) on the reduction of emergence agitation (EA) occurrence and EA severity in children who are receiving general anesthesia for a microscopic middle ear operation.

The 2 groups in the trial

  • group G (GANB group)Treatment being tested

    Patients in this group will receive a unilateral ultrasound-guided greater auricular nerve block (GANB) on the operative side, with a 0.5-1.5 mg/kg 0.25% Bupivacaine, immediately after induction of general anesthesia and prior to surgical incision

    Treatment: ultrasound-guided greater auricular nerve block (GANB)

  • group C (control group)No study treatment, for comparison

    Patients in this group will receive no nerve block, to maintain blinding, the ultrasound probe will be applied to the same anatomical region with no needle insertion or injection

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Efficacy of Ultrasound-guided Greater Auricular Nerve Block in Preventing Postoperative Emergence Agitation in Pediatric Patients Undergoing Microscopic Middle Ear Surgery: A PROSPECTIVE RANDOMIZED DOUBLE- BLINDED CLINICAL TRIAL
Criteria questions
Built from NCT07435675, who can take part
Record updated
27 February 2026